Like ancient mariners, ancestors of Prochlorococcus microbes rode out to sea on exoskeleton particles
A new study shows the carbon-capturing phytoplankton colonized the ocean by rafting on particles of chitin.
A new study shows the carbon-capturing phytoplankton colonized the ocean by rafting on particles of chitin.
MIT engineers’ new technique analyzes the 3D organization of the genome at a resolution 100 times higher than before.
The peptide blocks a hyperactive brain enzyme that contributes to the neurodegeneration seen in Alzheimer’s and other diseases.
A new analysis reveals how Staphylococcus aureus gains mutations that allow it to colonize eczema patches.
Geobiologist Greg Fournier seeks to uncover the conditions leading to the emergence of life.
Using these RNA-delivery particles, researchers hope to develop new treatments for cystic fibrosis and other lung diseases.
Using this approach, researchers hope to deliver therapeutic RNA molecules selectively to cancer cells or other target cells.
“Single-cell profiling” is helping neuroscientists see how disease affects major brain cell types and identify common, potentially targetable pathways.
MLK Visiting Professor tries to “maximize connection time” while studying protein evolution.
Prochlorococcus, the world’s most abundant photosynthetic organism, reveals a gene-transfer mechanism that may be key to its abundance and diversity.
Gene-Wei Li investigates the rules that cells use to maintain the correct ratio of the proteins they need to survive.
Known as PASTE, the technique holds potential for treating a variety of diseases caused by faulty genes.
In people carrying APOE4, a key brain cell mismanages cholesterol needed to insulate neurons properly — another sign APOE4 contributes to disease by disrupting brain lipids.
Researchers harness new pooled, image-based screening method to probe the functions of over 5,000 essential genes in human cells.
By analyzing enzyme activity at the organism, tissue, and cellular scales, new sensors could provide new tools to clinicians and cancer researchers.